FASN and breast carcinoma: The expression of fatty acid synthase (FASN), a key enzyme essential for the FAS, is elevated in breast cancer (57), and its upregulation appears to be connected with cancer development, recurrence and poor prognosis (58), suggesting the augmented FAS activity is important for breast cancer progression.